Member Description Overlay

Innovation in therapeutics has accelerated and broadened at unprecedented levels. Science has increased predictability. Predictability has led to corporate and investor confidence. This optimism has led to unprecedented valuations and market activity.

Investors and corporate clients value SVB Leerink’s insights and experience to assess the potential of high-quality, innovation-oriented growth companies. We integrate our understanding of the science, the unmet medical needs that are being addressed, the quality of the therapeutic solutions being studied and the capabilities of management teams to assess business opportunities.

We take pride in our ability to prepare and position our clients for capital markets and strategic transactions. Through this commitment to excellence, we have become a leading bookrunning manager of IPOs and follow-on offerings and an impactful M&A advisor.

We partner with our clients and are focused on their success and building long term relationships.